eNauka - pregled
Pregled prema Projekat Roche
Prikaz rezultata 1 do 20 od 114
sledeće >
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2017 | A Cross-Sectional Study On Predictors Of Lung Cancer Patients Delay Time In Serbia | Jovanovic, Dragana D; Perin, Branislav M; Velinovic, Milos M; Rancic, Milan H   ; Ceriman, Vesna K; Samardzic, Natalija V; Markovic, M | Conference Paper | Mp. category will be shown later |
| 2023 | A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care | El-Galaly, Tarec Christoffer; ...; Antić, Darko A. ; ...; (broj koautora 16) | Article | 21aM21a |
| 2025 | Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA) | Passiglia, Francesco; ...; Secen, Nevena; ...; (broj, koautora 36) | Article | 21a+M21a+ |
| 2016 | Addressing challenges for sustainable healthcare in Central and Eastern Europe | Godman, Brian; Novakovic, Tanja; Tesic, Danka; Oortwijn, Wija; Martin, Antony Paul; Parker, Mark; Haycox, Alan | Article | 22M22 |
| 2025 | Adverse side-effects of antifibrotic drugs and outcome of treatment in idiopathic pulmonary fibrosis | Jovanovic, Dragana; Mogulkoc, Nesrin; Sterclova, Martina; Kramer, Mordechai; Muller, Veronika; Bartos, Vladimir; Plackova, Martina; Doubkova, Martina; Lewandowska, Katarzyna; Szymanowska-Narloch, Amelia;
Zurkova, Monika; Ovesna, Petra; Koziar-Vasakova, Martina;
| Article | 22M22 |
| 2019 | Afatinib in locally advanced/metastatic NSCLC harboring common EGFR</i> mutations, after chemotherapy: a Phase IV study | Thongprasert, Sumitra; Geater, Sarayut L; Clement, Dana; Abdelaziz, Amr; Reyes-Igama, Jasmin; Jovanovic, Dragana; Alexandru, Aurelia; Schenker, Michael; Sriuranpong, Virote; Serwatowski, Piotr;
Suresh, Sheethal; Cseh, Agnieszka; Gaafar, Rabab;
| Article | Mp. category will be shown later |
| 2018 | Alemtuzumab and pregnancy - case series from the German MS and Pregnancy Registry, Norway and Serbia | Celius, EG; Ciplea, AI; Drulović, Jelena S. ; Thiel, S.; Gerbershagen, K.; Pekmezović, Tatjana D. ; Viehoever, A.; Gold, Ralf; Hellwig, K. | Conference Paper | Mp. category will be shown later |
| 2018 | Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome | Schwartz, GG; ...; Dilić, Mirza; ...; Ristić, Arsen D. ; ...; Simić, Dragan V. ; Ivanović, Nikola; Davidović, Goran T. ; Tasić, Nebojša M.;
Ašanin, Milika R.
; Stojić, Stevo; Apostolović, Svetlana R. ; Ilić, Stevan N.; Putniković, Biljana ; Stanković, Aleksandar; Arandjelovic, Aleksandra C. ; Radovanović, Slavica ; Balinovac, Jovan; Dinčić, Dragan V. ; Seferović, Petar M. ; Dodić, Slobodan S.; Dimković, Siniša ; ...; (broj, koautora 1390); | Article | 21a+M21a+ |
| 2019 | Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign | Suppa, M; ...; Medenica, Ljiljana M; ...; (broj, koautora 38) | Article | 21aM21a |
| 2021 | Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB plus ) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C | Dziadziuszko, R; ...; Andric, Zoran G ; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |
| 2020 | Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC | Herbst, Roy S; ...; Andric, Zoran G ; ...; (broj, koautora 22) | Article | 21a+M21a+ |
| 2022 | Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial | Peters, Solange; ...; Andric, Zoran G ; ...; (broj, koautora 26) | Article | 21a+M21a+ |
| 2019 | Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry | Cifkova, Renata; Lanska, Vera; Bruthans, Jan; Mayer, Otto Jr; Kotseva, Kornelia; Wood, David; Lovic, Dragan B ; De, Sutter Johan; Reiner, Zeljko; Fras, Zlatko;
Deckers, Jaap; Gotcheva, Nina; Georgiev, Borislav; De, Bacquer Dirk;
| Article | 21aM21a |
| 2017 | Brain and spinal cord imaging features in neuromyelitis optica spectrum disorder | Cacciaguerra, Laura; Rocca, Maria Assunta; Mesaroš, Šarlota T. ; Radaelli, Marta; Drulović, Jelena S. ; Pagani, Elisabetta; Martinelli, Vittorio; Dujmović-Bašuroski, Irena ; Comi, Giancarlo; Filippi, Massimo | Conference Paper | Mp. category will be shown later |
| 2025 | Brain health - time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 report | Butzkueven, Helmut; ...; Drulović, Jelena S. ; ...; (broj koautora 17) | Article | 21M21 |
| 2023 | Cerebrospinal fluid and MRI analyses of fenebrutinib treatment in multiple sclerosis reveal brain penetration and early reduction of new lesion activity: results from the phase II FENopta study | Bar-Or, Amit; Dufek, Michal; Budinčević, Hrvoje; Drulović, Jelena S. ; Habek, Mario; Hua, Le; Weber, Martin; Thomas, Piia; Napieralski, Julie; Clayton, David;
Kuruvilla, Denison; Qi, Qi; Xu, Yan; Goodyear, Alexandra; Oh, Jiwon;
| Conference Paper | Mp. category will be shown later |
| 2016 | Cerebrospinal fluid chitinase 3-like 1 levels in patients with radiologically isolated syndromes | Matute-Blanch, Clara; ...; Drulović, Jelena S. ; ...; (broj koautora 18) | Conference Paper | Mp. category will be shown later |
| 2015 | Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents | Karmiris, Konstantinos; ...; Tarabar, Dino K; ...; (broj, koautora 20) | Article | 21aM21a |
| 2024 | Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology | Agostinetto, Elisa; ...; Popovic, L ; ...; (broj, koautora 42) | Article | 21aM21a |
| 2020 | Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 | Herbst, Roy S; ...; Andric, Zoran G ; ...; (broj, koautora 21) | Conference Paper | Mp. category will be shown later |